Strengthening the FDA's Enforcement of ClinicalTrials.gov Reporting Requirements.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- December 7, 2021
published in
- JAMA Journal
has subject area
- Activin Receptors, Type II
- Antineoplastic Agents
- Axitinib
- Carcinoma, Renal Cell
- Clinical Trials as Topic
- Clinical Trials, Phase II as Topic
- Drug Industry
- Humans
- Immunoglobulin Fc Fragments
- Kidney Neoplasms
- Law Enforcement
- Mandatory Reporting
- National Institutes of Health (U.S.)
- Recombinant Fusion Proteins
- Registries
- United States
- United States Food and Drug Administration